Dennis J. Ahnen, MD (Deceased) | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!

Dennis J. Ahnen, MD

Associate Professor Emeritus
Division of Medicine
University of Colorado
12605 E. 16th Ave
Places : Dr. Ahnen’s Research Lab

Research Interests:

Dr. Ahnen’s research interests included the biologic and the biochemical mechanisms of the chemopreventive effects of the non-steroidal anti-inflammatory drugs (NSAIDs). He was examining the effect of NSAIDs on EGF receptor expression and function. His clinical trials group participated in several colorectal cancer prevention trials including several adenoma chemoprevention trials. He also collaborated with Al Marcus PhD and staff at the AMC Cancer Research Center to evaluate behavioral interventions to increase colorectal cancer screening rates in high-risk populations and he directed the Colorado site for two national cancer registries that identify high risk families for genetic and clinical trials.



Undergraduate: Florida State University

Medical School: Wayne State University

Fellowship: Gastroenterology University of Colorado Denver

Fellowship: Membrane Pathobiology, Stanford University


Representative Publication:

Chemoprevention of hereditary colon cancers: time for new strategies

Familial colon cancer syndromes: an update of a rapidly evolving field

expertly curated content related to this topic

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.